23 years after O'Farrel developed two-dimensional gel electrophoresis we st
ill debate if the technique can be improved, or if there are other alternat
ive separation technologies that can challenge its central position in prot
eomic projects. These questions are relevant as the pharmaceutical industry
expects proteomic studies to provide novel protein targets for drug discov
ery and diagnostics. In our opinion, there are various aspects of the techn
ology that can be improved, including resolution, sample preparation and de
tection, but so far there is no alternative technique(s) available, or any
under development, that can replace it.